Collagen Renewal & Skin Texture Improvement GHK-Cu stimulates fibroblast activity and upregulates key regenerative genes, including TGF- and VEGF, supporting improved skin firmness, elasticity, and youthful volume
The primary endpoint was change in bodyweight from baseline at 24 weeks, with 48 weeks included as a secondary outcome
Wider provision of the drugs through government-sponsored healthcare services, such as Medicare and Medicaid in the US, would be expected to further increase uptake and persistency, especially if prices are materially reduced through negotiated discounts with the pharmaceutical industry
More critically, the post-exercise anabolic window is dominated by insulin and mTOR signaling, which suppress GH receptor activity
Cosmetic-grade GHK-Cu is designed for topical use within finished products